CapsoVision, Inc (CV) income statement
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30733% above fair value
$6.82+0.17 (+2.56%)
Close on Nov 18, 2026Market cap $341.32MP/E –Yield –
CapsoVision, Inc income statement
Ratios
Latest available, balances at Jun 30, 2026
Profitability, TTM
- Gross margin
- 50.9%
- Operating margin
- -217.1%
- Net margin
- -214.7%
- Return on equity, FY2025
- 43.6%
Financial strength
- Current ratio
- 3.35
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- –
Valuation
- P/E ratio
- –
- Price to sales
- 24.57
- Price to book
- 25.92
- Dividend yield
- –
See a number that looks wrong?